APP and Alzheimer disease: Also, putting Wharton’s jelly-derived MSCs (WJ-MSCs) into an APP/PS1 AD mouse model through the tail vein decreased the number of reactive microglia and levels of pro-inflammatory factors (IL-1β and TNF-α) while increasing levels of IL-10, an anti-inflammatory factor (56).